lung cancer	is a	malignant tumor
smoking	is a risk factor for	lung cancer
asbestos exposure	is a risk factor for	lung cancer
radon exposure	is a risk factor for	lung cancer
air pollution	is a risk factor for	lung cancer
secondhand smoke	is a risk factor for	lung cancer
genetic predisposition	is a risk factor for	lung cancer
EGFR mutation	is associated with	lung cancer
KRAS mutation	is associated with	lung cancer
ALK fusion	is associated with	lung cancer
ROS1 rearrangement	is associated with	lung cancer
p53 mutation	is associated with	lung cancer
tumor suppressor gene mutation	is associated with	lung cancer
adenocarcinoma	is a histology of	lung cancer
squamous cell carcinoma	is a histology of	lung cancer
small cell carcinoma	is a histology of	lung cancer
large cell carcinoma	is a histology of	lung cancer
non-small cell lung cancer	is a type of	lung cancer
lung cancer	is treated with	platinum chemotherapy
lung cancer	is treated with	targeted therapy
lung cancer	is treated with	immunotherapy
platinum chemotherapy	includes	cisplatin
platinum chemotherapy	includes	carboplatin
cisplatin	is used in	lung cancer
carboplatin	is used in	lung cancer
pemetrexed	is used in	non-squamous NSCLC
pemetrexed	is used in	adenocarcinoma
pembrolizumab	is used in	lung cancer
nivolumab	is used in	lung cancer
atezolizumab	is used in	lung cancer
EGFR	is a target for	EGFR-mutated lung cancer
PD-L1 expression	predicts response to	pembrolizumab
tumor mutational burden	correlates with	immunotherapy response
low-dose CT	is used for	lung cancer screening
CT scan	is used in	diagnosis of lung cancer
PET-CT	is used for	staging of lung cancer
biopsy	is used to	diagnose lung cancer
cytology	is used for	diagnosis
EGFR mutation testing	informs	therapy choice
PD-L1 testing	informs	immunotherapy choice
smoking cessation	reduces	lung cancer risk
surgery	is curative for	early-stage lung cancer
lobectomy	is a surgical procedure for	lung cancer
pneumonectomy	is a surgical procedure for	lung cancer
radiation therapy	is used in	locally advanced lung cancer
stereotactic body radiotherapy	is used in	early-stage lung cancer
brachytherapy	provides	palliation
palliative care	is provided for	advanced lung cancer
delay in diagnosis	worsens	prognosis
performance status	influences	treatment choice
ECOG performance status	influences	treatment choice
bone metastasis	worsens	survival
brain metastasis	diminishes	quality of life
SIADH	is a paraneoplastic syndrome associated with	small cell lung cancer
hyponatremia	accompanies	SIADH
cachexia	is a comorbidity of	lung cancer
anxiety	coexists with	lung cancer
respiratory failure	results in	mortality
cytology	aids	diagnosis
tumor marker	has diagnostic utility in	lung cancer
carcinoembryonic antigen	is a tumor marker for	lung cancer
PET-CT	improves	staging accuracy
biomarker	predicts prognosis in	lung cancer
MRI	is performed for	brain metastasis evaluation
CSF analysis	detects	leptomeningeal metastasis
leptomeningeal metastasis	is a complication of	lung cancer
palliative radiotherapy	relieves	bone pain
bone metastasis	causes	bone pain
anemia	accompanies	lung cancer
thrombocytosis	accompanies	lung cancer
cough	is a symptom of	lung cancer
hemoptysis	is a symptom of	lung cancer
dyspnea	is a symptom of	lung cancer
weight loss	is a symptom of	lung cancer
fatigue	is a symptom of	lung cancer
screening	reduces	mortality from	lung cancer
early detection	improves	survival
clinic visit	indicates	suspected lung cancer
histology	influences	treatment choice
treatment plan	depends on	histology
response rate	correlates with	tumor mutation burden
response rate	higher with	targeted therapy
overall survival	improves with	immunotherapy
progression-free survival	is improved by	targeted therapy
adverse event	includes	neutropenia
neutropenia	is an adverse event of	chemotherapy
anemia	is an adverse event of	chemotherapy
nausea	is an adverse event of	chemotherapy
pneumonitis	is a potential toxicity of	immune checkpoint inhibitors
radiation pneumonitis	is a toxicity of	radiation therapy
brachytherapy	provides	palliation
staging	influences	treatment plan
multidisciplinary tumor board	coordinates	treatment plan
surgical margins	impact	recurrence risk
recurrence	follows	surgical resection
adjuvant therapy	reduces	recurrence risk
neutropenia	increases	infection risk
radiation therapy	causes	fatigue
transfusion	is used for	anemia
mortality	is an endpoint in	clinical trials
